Skip to main content

Books in Hematology

41-50 of 106 results in All results

Waldenström Macroglobulinemia, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 32-5
  • October 9, 2018
  • Jorge J Castillo + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 6 4 1 2 7 - 2
This issue of Hematology/Oncology Clinics, edited by Drs. Jorge J. Castillo, Efstathios Kastritis, and Steven P. Treon, will focus on Waldenström Macroglobulinemia. Topics include, but are not limited to, Genomics; Epigenomics; Flow cytometry; Marrow microenvironment; Familial Waldenstrom; MYD88 L265P and other MYD88 mutations; CXCR4 and other recurrent mutations; Diagnosis and differential diagnosis; Criteria to treat and treatment goals; Alkylators; Monoclonal antibodies; Proteasome inhibitors; BTK inhibitors; Transplant; and Novel approaches.

Consultative Hemostasis and Thrombosis

  • 4th Edition
  • September 27, 2018
  • Craig S. Kitchens + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 6 2 0 2 - 0
With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that’s new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors’ position that correct treatment begins with correct diagnosis. This trusted resource by Drs. Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, Michael B. Streiff, and David A. Garcia is designed for rapid reference and critical decision making at the point of care.

Thalassemia, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 32-2
  • March 6, 2018
  • Ali Taher
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 8 3 0 8 - 4
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 8 3 0 9 - 1
This issue of Hematology/Oncology Clinics, edited by Dr. Ali Taher, focuses on Thalassemia. Topics include, but are not limited to, Molecular basis and genetic modifiers; Evolving spectrum of epidemiology; Clinical classification; Ineffective erythropoiesis, anemia and iron overload; Hypercoagulability and vascular disease; Clinical complications and their management; Transfusion and iron chelation therapy; Hematopoietic Stem Cell Transplantation in Thalassemia; Gene therapy and genome editing; Emerging therapies; Quality of life; Advances in understanding pathophysiology and treatment of fertility, pregnancy, and prenatal diagnosis in Thalassemia; and MRI for iron overload.

Clinical Principles of Transfusion Medicine

  • 1st Edition
  • February 1, 2018
  • Robert W Maitta
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 4 4 5 8 - 0
Offering a concise overview of transfusion medicine, including best practices for specific clinical settings, this practical resource by Dr. Robert W. Maitta covers the key information you need to know. Holistic, multidisciplinary coverage and a succinct, easy-to-read format make it essential reading for transfusion specialists, as well as practitioners in other specialties whose patients undergo blood transfusions.

Dacie y Lewis. Hematología práctica

  • 12th Edition
  • November 20, 2017
  • Barbara J. Bain + 2 more
  • Spanish
  • eBook
    9 7 8 - 8 4 - 9 1 1 3 - 3 1 9 - 3
Durante más de 65 años, este éxito de ventas de los doctores Barbara Bain, Imelda Bates y Mike A. Laffan, ha sido la referencia en todo el mundo en hematología de laboratorio. Internacionalmente reconocida como la obra de referencia para los laboratorios de hematología, este manual práctico describe todas las técnicas utilizadas en la investigación de los pacientes con enfermedades sanguíneas. Analiza los principios de cada prueba, las causas posibles de error, el razonamiento para elegir un método u otro y la interpretación, significado e importancia clínica de los resultados. Aborda las últimas tecnologías y procedimientos en el trabajo de laboratorio. Incluye nueva información sobre seguridad en el laboratorio, proporcionando una guía sobre los riesgos de cada procedimiento. Hace hincapié en los detalles técnicos de los métodos, junto con una perspectiva crítica sobre su interpretación y utilidad clínica. Ofrece directrices útiles a todos los niveles, desde los centros primarios de salud, donde solo se realizan unas pocas pruebas diagnósticas, hasta centros especializados con tecnología sofisticada. Proporciona árboles de decisión que ayudan a enfrentarse a diversas situaciones clínicas desde el punto de vista de los análisis de laboratorio. Incluye capítulos sobre organización, dirección y control de calidad del laboratorio. Dispone de contenido adicional en ExpertConsult que permite búsquedas en todo el texto y referencias en una gran variedad de dispositivos.

Gene Therapy, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 31-5
  • September 19, 2017
  • Daniel E. Bauer + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 4 6 6 8 - 3
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 4 6 6 9 - 0
This issue of Hematology/Oncology Clinics will focus on Gene Therapy. Topics include, but are not limited to Historical Perspective and Current Renaissance, Integrating Vectors, Nonintegrating Vectors, Gene Editing, Conditioning Therapies for Autologous HSCT, Approaches to Immunodeficiency, Approaches to Hemoglobinopathy, Approaches to Hemophilia, Hematopoietic Gene Therapies for Neurologic and Metabolic Disease, Gene Therapy Approaches to HIV and other Infectious Diseases, HSC Approaches to Cancer, and Gene Modified T Cell Therapies for Cancer.

The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 31-4
  • July 11, 2017
  • Ann Mullally
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 3 2 3 5 - 8
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 3 2 3 6 - 5
This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

Upper Gastrointestinal Malignancies, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 31-3
  • May 23, 2017
  • Manish A. Shah
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 3 0 1 1 - 8
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 3 0 1 2 - 5
This issue of Hematology/Oncology Clinics will focus on Upper Gastrointestinal Malignancies; specifically, articles on the following: Epidemiology / Genetics, H. pylori and the gastric microbiome in gastric cancer carcinogenesis; Barrett’s esophagus and esophageal cancer; Tumor Staging; Localized disease; Metastatic Disease; Immunotherapy Antiangiogenic therapy; and many more!

T-Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America

  • 1st Edition
  • Volume 31-2
  • March 30, 2017
  • Eric D. Jacobsen
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 2 4 1 0 - 0
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 2 4 1 1 - 7
This issue of Hematology/Oncology Clinics will feature articles such as: Anaplastic large cell lymphomaj; New agents; Transplant, Uncommon variants; ATLL, CD30+ LPD of skin; NK/T, MF/SS; and many more!

Lung Cancer, An Issue of Hematology/Oncology Clinics

  • 1st Edition
  • Volume 31-1
  • December 3, 2016
  • Roy S. Herbst + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 9 6 5 0 - 6
  • eBook
    9 7 8 - 0 - 3 2 3 - 4 9 6 6 0 - 5
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!